KeyBank National Association’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,977
| Closed | -$217K | – | 1114 |
|
|
2023
Q3 | $217K | Hold |
2,977
| – | – | ﹤0.01% | 958 |
|
|
2023
Q2 | $248K | Buy |
+2,977
| New | +$248K | ﹤0.01% | 951 |
|
|
2023
Q1 | – | Sell |
-2,652
| Closed | -$220K | – | 1098 |
|
|
2022
Q4 | $220K | Buy |
2,652
+75
| +3% | +$6.23K | ﹤0.01% | 978 |
|
|
2022
Q3 | $204K | Buy |
+2,577
| New | +$204K | ﹤0.01% | 985 |
|
|
2022
Q2 | – | Sell |
-2,465
| Closed | -$222K | – | 1135 |
|
|
2022
Q1 | $222K | Sell |
2,465
-400
| -14% | -$36K | ﹤0.01% | 1003 |
|
|
2021
Q4 | $321K | Buy |
2,865
+13
| +0.5% | +$1.46K | ﹤0.01% | 918 |
|
|
2021
Q3 | $359K | Sell |
2,852
-40
| -1% | -$5.04K | ﹤0.01% | 894 |
|
|
2021
Q2 | $392K | Sell |
2,892
-18
| -0.6% | -$2.44K | ﹤0.01% | 858 |
|
|
2021
Q1 | $395K | Buy |
2,910
+248
| +9% | +$33.7K | ﹤0.01% | 854 |
|
|
2020
Q4 | $375K | Hold |
2,662
| – | – | ﹤0.01% | 846 |
|
|
2020
Q3 | $297K | Sell |
2,662
-20
| -0.7% | -$2.23K | ﹤0.01% | 834 |
|
|
2020
Q2 | $300K | Hold |
2,682
| – | – | ﹤0.01% | 817 |
|
|
2020
Q1 | $208K | Sell |
2,682
-1,286
| -32% | -$99.7K | ﹤0.01% | 851 |
|
|
2019
Q4 | $377K | Buy |
3,968
+966
| +32% | +$91.8K | ﹤0.01% | 802 |
|
|
2019
Q3 | $229K | Sell |
3,002
-48
| -2% | -$3.66K | ﹤0.01% | 902 |
|
|
2019
Q2 | $268K | Buy |
3,050
+100
| +3% | +$8.79K | ﹤0.01% | 899 |
|
|
2019
Q1 | $267K | Hold |
2,950
| – | – | ﹤0.01% | 857 |
|
|
2018
Q4 | $212K | Hold |
2,950
| – | – | ﹤0.01% | 878 |
|
|
2018
Q3 | $283K | Hold |
2,950
| – | – | ﹤0.01% | 921 |
|
|
2018
Q2 | $281K | Buy |
+2,950
| New | +$281K | ﹤0.01% | 896 |
|
|
2013
Q3 | – | Sell |
-35,400
| Closed | -$1.23M | – | 1311 |
|
|
2013
Q2 | $1.23M | Buy |
+35,400
| New | +$1.23M | ﹤0.01% | 735 |
|